The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.
The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment BURLINGTON, N.C., April 10, 2024 /PRNewswire/ -- ...
Medical Device Network on MSN
NAMSA acquires Labcorp’s medical device testing assets
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect the ...
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback